Bryan D. Kynnap
Broad Institute(US)Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Renal and related cancers, Chromatin Remodeling and Cancer, Cancer Mechanisms and Therapy, Renal cell carcinoma treatment
Most-Cited Works
- → Integrated genetic and pharmacologic interrogation of rare cancers(2016)56 cited
- → Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition(2019)50 cited
- → Sirtuin 6 is required for the integrated stress response and resistance to inhibition of transcriptional cyclin-dependent kinases(2023)13 cited
- → MCL1 and DEDD Promote Urothelial Carcinoma Progression(2019)9 cited
- → Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin(2024)7 cited
- → Targeting TRIP13 in Wilms Tumor with Nuclear Export Inhibitors(2022)5 cited
- → Figure S1 from MCL1 and DEDD Promote Urothelial Carcinoma Progression(2023)
- → Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition(2018)
- → Figure S3 from MCL1 and DEDD Promote Urothelial Carcinoma Progression(2023)
- → Data from MCL1 and DEDD Promote Urothelial Carcinoma Progression(2023)